Navigation Links
Lung Cancer Evolves With Treatment, Study Finds

WEDNESDAY, March 23 (HealthDay News) -- A new study helps explain how some lung cancers become resistant to targeted drug therapy.

Researchers at the Massachusetts General Hospital Cancer Center analyzed tumor samples from 37 patients with non-small cell lung cancer, the leading cause of cancer death worldwide, and identified two new genetic changes associated with resistance.

They also confirmed resistance-related genetic changes identified in previous studies.

The MGH team also discovered that the cellular nature of some tumors changes in response to treatment and that genetic mutations associated with drug resistance can disappear after treatment is halted.

The findings highlight the importance of monitoring the molecular status of lung cancer tumors throughout the treatment process, the researchers said.

"It is really remarkable how much we oncologists assume about a tumor based on a single biopsy taken at one time, usually the time of diagnosis," lead author Dr. Lecia Sequist said in an MGH news release. "Many cancers can evolve in response to exposure to different therapies over time, and we may be blind to the implications of these changes simply because we haven't been looking for them."

"Our findings suggest that, when feasible, oncogene-driven cancers should be interrogated with repeat biopsies throughout the course of the disease," Sequist said. "Doing so could both contribute to greater understanding of acquired resistance and give caregivers better information about whether resumption of targeted therapy or initiation of a standard therapy would be most appropriate for an individual patient."

The study appears March 23 in the journal Science Translational Medicine.

More information

The American Cancer Society has more about non-small-cell lung cancer.

-- Robert Preidt

SOURCE: Massachusetts General Hospital, news release, March 23, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins make radiation more effective at curing prostate cancer
2. UT MD Anderson receives grant for study of acupuncture in cancer
3. Discovery in liver cancer cells provides new target for drugs
4. Tamoxifen May Offer Long-Term Heart, Cancer Protection
5. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
6. Good news for meat lovers: Most ready-to-eat meat products contain very few cancerous compounds
7. Philanthropic pledge triples funds for TGen ovarian cancer research
8. Smoke-Free Environments Linked to Less Breast Cancer
9. The MMRF and John Theurer Cancer Center to host patient symposium
10. Does selenium prevent cancer? It may depend on which form people take
11. Malaria drug slows pancreatic cancer growth in mouse models
Post Your Comments:
Related Image:
Lung Cancer  Evolves With Treatment, Study Finds
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: